Vasomedical Proves Itself A Company To Watch On The Fast Track to Growth

With the recent acquisition of the two Chinese companies, restructuring, and the addition of a new CFO, Vasomedical is now positioned to move forward and further implement plans for expansion and growth.

Read more »

Vasomedical Announces Agreement to Acquire Two China-Based Companies

Further Implements Global Growth Strategy and Strengthens Manufacturing, Distribution and Technology Base

Read more »

Dr. Jun Ma Discusses Biox Monitors and Future of Cardiac Care

Vasomedical (OTC: VASO) President & CEO Jun Ma, Ph.D., was interviewed by OneMedRadio. Vasomedical is a Westbury, New York device company with a market cap of $39M focusing on cardiac disease.

Read more »